Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART‐2 study

Autor:	Masanobu Miura, Yasuhiko Sakata, Masayuki Sato, Ruri Abe, Chart Investigators, Takashi Shiroto, Koichiro Sugimura, Kotaro Nochioka, Takahide Fujihashi, Hajime Aoyanagi, Jun Takahashi, Hideka Hayashi, Shinsuke Yamanaka, Shintaro Kasahara, Satoshi Miyata, Hiroaki Shimokawa
Rok vydání:	2020
Předmět:	lcsh:Diseases of the circulatory (Cardiovascular) system medicine.medical_specialty Heart failure 030204 cardiovascular system & hematology Gastroenterology Ventricular Function Left 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Original Research Articles Internal medicine medicine Humans Original Research Article 030212 general & internal medicine Aged Aged 80 and over Creatinine Ejection fraction Proportional hazards model business.industry Incidence (epidemiology) Hazard ratio Stroke Volume Atrial fibrillation Biomarker Middle Aged Prognosis medicine.disease Confidence interval chemistry lcsh:RC666-701 Female Cardiology and Cardiovascular Medicine business Uric acid
Zdroj:	ESC Heart Failure, Vol 8, Iss 2, Pp 1027-1038 (2021) ESC Heart Failure
ISSN:	2055-5822
DOI:	10.1002/ehf2.12765
Popis:	Aims Prognostic impacts of serum uric acid (UA) levels in patients with chronic heart failure (CHF) remain inconclusive, especially for the whole range of serum UA levels. Methods and results In the Chronic Heart Failure Registry and Analysis in the Tohoku District‐2 (CHART‐2) study, we enrolled 4652 consecutive patients with CHF and classified them into four groups based on baseline serum UA levels by the Classification and Regression Tree: G1 (9.2 mg/dL, N = 251). Mean age was 71 ± 12, 69 ± 12, 68 ± 13, and 69 ± 15 years in G1, G2, G3, and G4, respectively (P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572a3b2a4609a926cee036b3d82c63b9 https://doi.org/10.1002/ehf2.12765 Zobrazit plný text záznamu Plný text